Is Progestrade (CLONE) a Scam?

When we at FXCanary sit down to judge whether a broker is safe to trade with, we do not rely on marketing brochures or a slick website. Our methodology starts with the hard, verifiable facts: the regulatory licences a broker holds, the jurisdiction in which it is registered, and whether its public claims match what the official registers actually say. We then layer on operational signals — how long the firm has been active, whether it has a verifiable physical presence, and whether independent users have reported problems. For a broker with no track record and no independent reviews, that evidence base is thin, and the absence of verification is itself a finding.

For Progestrade (CLONE), our records show a Scam Risk Score of 55 out of 100, which we classify as 'Elevated'. That score is built from two specific red flags: there is no verified regulatory licence on file, and there is no verifiable website or social-media presence. In plain terms, this means we could not confirm that the entity operating under this name is authorised by any financial regulator, and we could not find a credible digital footprint that would allow a trader to independently check who they are dealing with. In FXCanary's assessment, that combination is exactly the kind of profile that should make a cautious trader stop and think before depositing a single dollar.

The most important fact about Progestrade (CLONE) is that our records list no regulators and no licences on file. That is not a minor omission — it is the central issue. A regulated broker is subject to capital requirements, conduct rules, and periodic audits, and it must hold client money in segregated accounts under a recognised regime. An unregulated broker answers to no one. There is no external body to complain to, no compensation scheme to fall back on, and no guarantee that the firm is even operating in the way it claims.

We cross-checked the public register and found no matching authorisation. It is possible that the firm operates in a jurisdiction where licensing is not required, or that it has applied for a licence that has not yet been granted, but we have no evidence of either. The burden of proof lies with the broker, and in this case the broker has not met it. For a trader, the practical implication is stark: if something goes wrong — a withdrawal is refused, a platform freezes, or the firm simply disappears — there is no regulator to turn to and no safety net to recover funds.

In jurisdictions with strong oversight, client funds are protected by a combination of segregation, compensation schemes, and negative-balance protection. Segregation means your money is held in a separate account from the broker's own operating funds, so if the broker goes bankrupt, your money is not part of the insolvency estate. Compensation schemes, such as the UK's Financial Services Compensation Scheme or the EU's investor compensation funds, provide a payout — typically up to a set limit — if the broker fails. Negative-balance protection ensures you cannot lose more than you deposited, even in volatile markets.

None of these protections apply to Progestrade (CLONE), because none of these protections are tied to a licence. Without a regulator, there is no requirement to segregate client funds, no obligation to participate in a compensation scheme, and no guarantee of negative-balance protection. In our assessment, this is not a theoretical risk but a concrete one. A broker with no licence can hold client money in its own accounts, use it for operating expenses, or simply abscond with it. The lack of a compensation scheme means that even a successful legal claim would likely yield nothing if the firm has no assets.

The name 'Progestrade (CLONE)' is itself a warning. The word 'clone' in the label is not a coincidence — it reflects a common pattern in the forex industry where fraudsters set up a website that mimics a legitimate, regulated broker, using a similar name or domain to trick traders into thinking they are dealing with the real firm. In this case, our records show zero clone or impersonator sites found, which is unusual. That could mean the name is so obscure that no one has bothered to clone it, or it could mean that the entity itself is the clone of a larger, more established brand.

We searched the web for references to Progestrade and found results that may describe a different entity with a similar name. This is a classic red flag: when a broker's name is easily confused with another firm, the risk of a trader being misled increases dramatically. Even if the web results do not directly match this broker, the confusion is enough to warrant caution. In our view, a trader who sees the name 'Progestrade' should verify the exact domain and check the regulator's register before proceeding. If the domain does not match the official one, or if the regulator's register shows no licence, walk away.

We also note that Progestrade (CLONE) has no independent user reviews on file. In the forex world, reviews are a double-edged sword — they can be faked, but their total absence is equally telling. A broker that has been operating for any length of time, even a small one, typically accumulates some feedback on forums, review sites, or social media. The fact that we found none suggests either that the broker is very new, that it has deliberately kept a low profile, or that it has not attracted genuine clients.

For a trader, the lack of reviews is not a neutral fact. It means there is no community knowledge to draw on, no one to warn you about withdrawal problems, and no one to confirm that the platform works as advertised. In our assessment, the absence of independent verification is a significant risk factor. We would rather see a few negative reviews that we can weigh than a void of information, because a void leaves room for the broker to define its own narrative without challenge.

If you are still tempted to trade with Progestrade (CLONE), we urge you to take a series of practical steps before committing any funds. First, verify the domain. The official domain in our records is http://www.progestrade.com/ — if you are on a different site, you are not dealing with the entity we reviewed.

Second, check the regulator's register in your own jurisdiction. If the broker claims to be regulated, ask for the licence number and verify it directly on the regulator's website. If they cannot provide one, or if the number does not match, treat that as a definitive red flag.

Third, test the withdrawal process with a small deposit before committing more. A common scam pattern is to allow small withdrawals initially to build trust, then block larger ones. Fourth, use a separate email address and a virtual private network (VPN) when signing up, to limit the amount of personal data you expose.

Finally, consider whether the potential returns are worth the risk. In our assessment, the elevated risk score of 55/100 is not a recommendation to trade — it is a warning that the safety net is missing. If you do proceed, do so only with money you can afford to lose entirely.

In FXCanary's assessment, Progestrade (CLONE) is a broker that fails the basic test of verifiable legitimacy. It has no regulatory licence on file, no verifiable website or social-media presence, and no independent user reviews. The name itself suggests a potential clone or impersonation risk, and our web search results did not clearly match this entity, adding to the confusion. While we have not found evidence of outright fraud, the absence of evidence is not evidence of safety.

We would advise any trader to treat this broker as high-risk until it can demonstrate, with verifiable documentation, that it is licensed and regulated. The burden of proof is on the broker, and so far it has not met it. For now, the safest course is to avoid depositing funds and to seek out a broker that is properly regulated in your jurisdiction, with a clear compensation scheme and a track record of independent reviews. In the world of forex, the cost of a mistake can be the loss of your entire deposit — and with Progestrade (CLONE), that risk is real.